BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17952009)

  • 21. Repeatability of automated perimetry: a comparison between standard automated perimetry with stimulus size III and V, matrix, and motion perimetry.
    Wall M; Woodward KR; Doyle CK; Artes PH
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):974-9. PubMed ID: 18952921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of matrix frequency-doubling technology perimetry and standard automated perimetry in monitoring the development of visual field defects for glaucoma suspect eyes.
    Hu R; Wang C; Racette L
    PLoS One; 2017; 12(5):e0178079. PubMed ID: 28542536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing the use of frequency doubling technology perimetry in community vision screenings.
    Nehmad L; Madonna RJ
    Optom Vis Sci; 2008 Jul; 85(7):559-65. PubMed ID: 18594349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-function relationship between FDF, FDT, SAP, and scanning laser ophthalmoscopy in glaucoma patients.
    Lamparter J; Russell RA; Schulze A; Schuff AC; Pfeiffer N; Hoffmann EM
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7553-9. PubMed ID: 23074201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the high specificity Screening Program (C-20-1) of the Frequency Doubling Technology (FDT) perimeter in clinical practice.
    North RV; Jones AL; Hunter E; Morgan JE; Wild JM
    Eye (Lond); 2006 Jun; 20(6):681-7. PubMed ID: 15999135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of frequency doubling technology perimetry and achromatic standard automated perimetry in patients with migraine without aura and controls].
    Göbel K; Boyraz M; Schröder A; Erb C
    Klin Monbl Augenheilkd; 2008 Aug; 225(8):718-22. PubMed ID: 18712657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glaucoma progression detection with frequency doubling technology (FDT) compared to standard automated perimetry (SAP) in the Groningen Longitudinal Glaucoma Study.
    Wesselink C; Jansonius NM
    Ophthalmic Physiol Opt; 2017 Sep; 37(5):594-601. PubMed ID: 28836391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Initial findings with pulsar perimetry in patients with ocular hypertension].
    Vidal-Fernández A; García Feijoó J; González-Hernández M; González De La Rosa M; García Sánchez J
    Arch Soc Esp Oftalmol; 2002 Jun; 77(6):321-6. PubMed ID: 12058290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-wavelength automated perimetry and frequency-doubling technology perimetry in glaucoma.
    Fogagnolo P; Rossetti L; Ranno S; Ferreras A; Orzalesi N
    Prog Brain Res; 2008; 173():101-24. PubMed ID: 18929104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Learning effect among perimetric novices with screening C-20-1 frequency doubling technology perimetry.
    Brush MB; Chen PP
    Am J Ophthalmol; 2004 Mar; 137(3):551-2. PubMed ID: 15013879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Learning effect of short-wavelength automated perimetry in patients with ocular hypertension.
    Rossetti L; Fogagnolo P; Miglior S; Centofanti M; Vetrugno M; Orzalesi N
    J Glaucoma; 2006 Oct; 15(5):399-404. PubMed ID: 16988602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for improving the diagnostic specificity of the frequency doubling perimeter.
    Heeg GP; Stoutenbeek R; Jansonius NM
    Acta Ophthalmol Scand; 2005 Feb; 83(1):53-6. PubMed ID: 15715557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of learning effect on frequency doubling technology perimetry (Matrix).
    Contestabile MT; Perdicchi A; Amodeo S; Recupero V; Recupero SM
    J Glaucoma; 2007 May; 16(3):297-301. PubMed ID: 17438423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The results of screening frequency doubling technology perimetry in different locations of the community.
    Mansberger SL; Johnson CA; Cioffi GA
    J Glaucoma; 2007 Jan; 16(1):73-80. PubMed ID: 17224754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of test reliability on the screening performance of frequency-doubling perimetry.
    Heeg GP; Jansonius NM
    Am J Ophthalmol; 2006 Mar; 141(3):585-7. PubMed ID: 16490521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Update on glaucoma diagnosis and follow-up].
    González de la Rosa MA
    Arch Soc Esp Oftalmol; 2003 Jun; 78(6):299-314. PubMed ID: 12838462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency doubling technology staging system 2.
    Brusini P
    J Glaucoma; 2006 Aug; 15(4):315-20. PubMed ID: 16865009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparing the ranges of defect measured with standard white on white and Pulsar perimetries].
    González de la Rosa M; González-Hernández M; García-Feijoo J; Sánchez Méndez M; García-Sánchez J
    Arch Soc Esp Oftalmol; 2011 Apr; 86(4):113-7. PubMed ID: 21569920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Standard Automated Perimetry, Short-Wavelength Automated Perimetry, and Frequency-Doubling Technology Perimetry to Monitor Glaucoma Progression.
    Hu R; Wang C; Gu Y; Racette L
    Medicine (Baltimore); 2016 Feb; 95(7):e2618. PubMed ID: 26886602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic capability of PULSAR, FDT y HRT-II in glaucoma suspects].
    González-de-la-Rosa M; González-Hernández M; Aguilar-Estévez J; Díaz-Alemán T; Armas-Plasencia R
    Arch Soc Esp Oftalmol; 2007 Jul; 82(7):413-22. PubMed ID: 17647116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.